Two novel variants in the 3UTR of the BRCA1 gene in familial breast and/or ovarian cancer

Breast Cancer Research and Treatment

Volumn 125, Issue 3, 2011, Pages 885-891

  Lheureux, Stéphanie ^a   Lambert, Bernard ^a   Krieger, Sophie ^a   Legros, Angelina ^a   Vaur, Dominique ^a   Denoyelle, Christophe ^a   Berthet, Pascaline ^a   Poulain, Laurent ^a   Hardouin, Agnès ^a  

^a Centre de Lutte Contre le Cancer François Baclesse   (France)

Author keywords

3UTR; BRCA; Breast; Inherited cancer; miRNA; Ovarian

Indexed keywords

BRCA1 PROTEIN; GENOMIC DNA; LUCIFERASE; MICRORNA;

3' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CONTROLLED STUDY; FAMILIAL CANCER; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OVARY CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; REPORTER GENE; RNA BINDING; ADULT; BREAST TUMOR; DNA SEQUENCE; FAMILY HEALTH; FEMALE; GENE DELETION; GENETICS; METABOLISM; MIDDLE AGED; OVARY TUMOR; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

3' UNTRANSLATED REGIONS; ADULT; BREAST NEOPLASMS; FAMILY HEALTH; FEMALE; GENE DELETION; GENES, BRCA1; GENETIC VARIATION; GENOTYPE; HUMANS; LUCIFERASES; MICRORNAS; MIDDLE AGED; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 79151482387     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1165-8     Document Type: Article

References (22)

1. Y Miki J Swensen D Shattuck-Eidens PA Futreal K Harshman S Tavtigian Q Liu C Cochran LM Bennett W Ding 1994 A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66 71 1:CAS:528: DyaK2MXhtF2ns70%3D 10.1126/science.7545954 7545954 (Pubitemid 24345325)
2. R Wooster G Bignell J Lancaster S Swift S Seal J Mangion N Collins S Gregory C Gumbs G Micklem 1995 Identification of the breast cancer susceptibility gene BRCA2 Nature 378 789 792 1:CAS:528:DyaK28XltFWi 10.1038/378789a0 8524414 (Pubitemid 26004412)
3. S Chen G Parmigiani 2007 Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 1329 1333 10.1200/JCO.2006.09.1066 17416853 (Pubitemid 46706879)
4. M Robson K Offit 2007 Clinical practice. Management of an inherited predisposition to breast cancer N Engl J Med 357 154 162 1:CAS:528: DC%2BD2sXnslSjsbk%3D 10.1056/NEJMcp071286 17625127 (Pubitemid 47057733)
5. Hennessy BT, Timms KM, Carey MS, Gutin A, Meyer LA, Flake DD, Abkevich V, Potter J, Pruss D, Glenn P, Li Y, Li J, Gonzalez-Angulo AM, McCune KS, Markman M, Broaddus RR, Lanchbury JS, Lu KH, Mills GB (2010) Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly(ADP ribose) polymerase inhibitors in ovarian cancer. J Clin Oncol 28:3570-3576
6. MW Audeh J Carmichael RT Penson M Friedlander B Powell KM Bell-McGuinn C Scott JN Weitzel A Oaknin M Robson N Loman K Lu RK Schmutzler U Matulonis M Wickens A Tutt 2010 Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial Lancet 376 245 251 1:CAS:528:DC%2BC3cXpt1Kktb4%3D 10.1016/S0140-6736(10)60893-8 20609468
7. A Tutt M Robson JE Garber SM Domchek MW Audeh JN Weitzel M Friedlander B Arun N Loman RK Schmutzler A Wardley G Mitchell G Earl M Wickens J Carmichael 2010 Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial Lancet 376 235 244 1:CAS:528:DC%2BC3cXpt1KktLc%3D 10.1016/S0140-6736(10)60892-6 20609467
8. D Ford DF Easton M Stratton S Narod D Goldgar P Devilee DT Bishop B Weber G Lenoir J Chang-Claude H Sobol MD Teare J Struewing A Arason S Scherneck J Peto TR Rebbeck P Tonin S Neuhausen R Barkardottir J Eyfjord H Lynch BA Ponder SA Gayther M Zelada-Hedman 1998 Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 676 689 1:CAS:528:DyaK1MXlvFeh 10.1086/301749 9497246 (Pubitemid 28164626)
9. JD Fackenthal OI Olopade 2007 Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations Nat Rev Cancer 7 937 948 1:CAS:528: DC%2BD2sXhtlCrsLbK 10.1038/nrc2054 18034184 (Pubitemid 350165853)
10. TW Nilsen 2007 Mechanisms of microRNA-mediated gene regulation in animal cells Trends Genet 23 243 249 1:CAS:528:DC%2BD2sXkslensbs%3D 10.1016/j.tig.2007.02.011 17368621 (Pubitemid 46628981)
11. T Kontorovich A Levy M Korostishevsky U Nir E Friedman 2010 Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women Int J Cancer 127 589 597 1:CAS:528:DC%2BC3cXmslSntrY%3D 10.1002/ijc.25065 19950226
12. M Pongsavee V Yamkamon S Dakeng P Charoenrat DR Smith GF Saunders P Patmasiriwat 2009 The BRCA1 3-UTR: 5711+421T/T-5711+1286T/T genotype is a possible breast and ovarian cancer risk factor Genet Test Mol Biomarkers 13 307 317 1:CAS:528:DC%2BD1MXotFSns7w%3D 10.1089/gtmb.2008.0127 19405875
13. MS Nicoloso H Sun R Spizzo H Kim P Wickramasinghe M Shimizu SE Wojcik J Ferdin T Kunej L Xiao S Manoukian G Secreto F Ravagnani X Wang P Radice CM Croce RV Davuluri GA Calin 2010 Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility Cancer Res 70 2789 2798 1:CAS:528:DC%2BC3cXktFyntrg%3D 10.1158/0008-5472.CAN-09-3541 20332227
14. N Puget D Stoppa-Lyonnet OM Sinilnikova S Pages HT Lynch GM Lenoir S Mazoyer 1999 Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions Cancer Res 59 455 461 1:CAS:528:DyaK1MXntFOisw%3D%3D 9927062
15. CY Liu A Flesken-Nikitin S Li Y Zeng WH Lee 1996 Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development Genes Dev 10 1835 1843 1:CAS:528: DyaK28Xks1OntLg%3D 10.1101/gad.10.14.1835 8698242
16. A Meyerhans JP Vartanian S Wain-Hobson 1990 DNA recombination during PCR Nucleic Acids Res 18 1687 1691 1:CAS:528:DyaK3cXitFWqtL8%3D 10.1093/nar/18.7. 1687 2186361
17. MS Judo AB Wedel C Wilson 1998 Stimulation and suppression of PCR-mediated recombination Nucleic Acids Res 26 1819 1825 1:CAS:528: DyaK1cXis1Oju7o%3D 10.1093/nar/26.7.1819 9512558 (Pubitemid 28291822)
18. J Shen CB Ambrosone H Zhao 2009 Novel genetic variants in microRNA genes and familial breast cancer Int J Cancer 124 1178 1182 1:CAS:528: DC%2BD1MXhvFCltrk%3D 10.1002/ijc.24008 19048628
19. Gao LB, Bai P, Pan XM, Jia J, Li LJ, Liang WB, Tang M, Zhang LS, Wei YG, Zhang L (2010) The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat. doi: 10.1007/s10549-010-0993-x
20. I Catucci R Yang P Verderio S Pizzamiglio L Heesen K Hemminki C Sutter B Wappenschmidt M Dick N Arnold P Bugert D Niederacher A Meindl RK Schmutzler CC Bartram F Ficarazzi L Tizzoni D Zaffaroni S Manoukian M Barile MA Pierotti P Radice B Burwinkel P Peterlongo 2010 Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases Hum Mutat 31 E1052 E1057 10.1002/humu.21141 19847796
21. PM Campeau WD Foulkes MD Tischkowitz 2008 Hereditary breast cancer: new genetic developments, new therapeutic avenues Hum Genet 124 31 42 1:CAS:528:DC%2BD1cXot1Wht78%3D 10.1007/s00439-008-0529-1 18575892
22. T Walsh MK Lee S Casadei AM Thornton SM Stray C Pennil AS Nord JB Mandell EM Swisher MC King 2010 Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing Proc Natl Acad Sci USA 107 12629 12633 1:CAS:528:DC%2BC3cXpt1ehsr0%3D 10.1073/pnas.1007983107 20616022